Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tuberous Sclerosis | 6 | 2019 | 1030 | 1.370 |
Why?
|
Proteus Syndrome | 3 | 2019 | 13 | 1.330 |
Why?
|
Mohs Surgery | 2 | 2021 | 222 | 1.190 |
Why?
|
2-Propanol | 1 | 2024 | 28 | 0.900 |
Why?
|
Lasers, Gas | 2 | 2020 | 101 | 0.810 |
Why?
|
Nevus | 3 | 2019 | 205 | 0.780 |
Why?
|
Acne Vulgaris | 2 | 2024 | 358 | 0.720 |
Why?
|
Cutis Laxa | 1 | 2020 | 29 | 0.700 |
Why?
|
Wound Closure Techniques | 1 | 2020 | 87 | 0.650 |
Why?
|
Coronavirus | 1 | 2020 | 154 | 0.590 |
Why?
|
Foot Diseases | 1 | 2017 | 147 | 0.540 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 2017 | 114 | 0.510 |
Why?
|
Skin Neoplasms | 6 | 2023 | 5821 | 0.510 |
Why?
|
Skin | 4 | 2024 | 4484 | 0.500 |
Why?
|
Angiofibroma | 1 | 2015 | 55 | 0.500 |
Why?
|
Mosaicism | 2 | 2019 | 475 | 0.470 |
Why?
|
Physician's Role | 1 | 2021 | 917 | 0.460 |
Why?
|
Dermatology | 3 | 2020 | 918 | 0.450 |
Why?
|
Tumor Suppressor Proteins | 4 | 2019 | 2803 | 0.410 |
Why?
|
Fellowships and Scholarships | 1 | 2021 | 1117 | 0.400 |
Why?
|
Lower Extremity | 1 | 2020 | 1202 | 0.390 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2015 | 678 | 0.380 |
Why?
|
Surgical Wound Infection | 1 | 2020 | 1527 | 0.360 |
Why?
|
Sirolimus | 1 | 2015 | 1533 | 0.310 |
Why?
|
Skin Diseases | 1 | 2017 | 1094 | 0.300 |
Why?
|
Ribosomal Protein S6 | 2 | 2017 | 71 | 0.270 |
Why?
|
Eccrine Porocarcinoma | 1 | 2023 | 18 | 0.220 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3204 | 0.200 |
Why?
|
Sweat Gland Neoplasms | 1 | 2023 | 116 | 0.190 |
Why?
|
Disinfection | 1 | 2024 | 211 | 0.190 |
Why?
|
Pamphlets | 1 | 2021 | 71 | 0.190 |
Why?
|
Internship and Residency | 1 | 2021 | 5880 | 0.180 |
Why?
|
Proteus | 1 | 2020 | 11 | 0.180 |
Why?
|
Deoxycholic Acid | 1 | 2020 | 53 | 0.180 |
Why?
|
Enterobacter | 1 | 2020 | 44 | 0.180 |
Why?
|
Hyperemia | 1 | 2021 | 221 | 0.170 |
Why?
|
Pseudomonas | 1 | 2020 | 124 | 0.170 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2019 | 2455 | 0.160 |
Why?
|
Laser Therapy | 1 | 2024 | 1092 | 0.140 |
Why?
|
Microvessels | 1 | 2021 | 577 | 0.140 |
Why?
|
Microcirculation | 1 | 2021 | 1273 | 0.130 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2017 | 126 | 0.130 |
Why?
|
Angiography | 1 | 2021 | 1595 | 0.130 |
Why?
|
Neck | 1 | 2020 | 734 | 0.130 |
Why?
|
Galectin 3 | 1 | 2017 | 240 | 0.130 |
Why?
|
Aminopyridines | 1 | 2019 | 573 | 0.120 |
Why?
|
Oral Ulcer | 1 | 2015 | 96 | 0.120 |
Why?
|
Young Adult | 7 | 2024 | 59243 | 0.120 |
Why?
|
Pain | 2 | 2020 | 5073 | 0.120 |
Why?
|
Nipples | 1 | 2015 | 229 | 0.110 |
Why?
|
Imidazoles | 1 | 2019 | 1180 | 0.100 |
Why?
|
Retrospective Studies | 7 | 2020 | 80636 | 0.100 |
Why?
|
Humans | 21 | 2024 | 761504 | 0.100 |
Why?
|
Adolescent | 6 | 2024 | 88319 | 0.100 |
Why?
|
Staphylococcus aureus | 1 | 2020 | 1458 | 0.100 |
Why?
|
PTEN Phosphohydrolase | 1 | 2017 | 1115 | 0.090 |
Why?
|
Patient Education as Topic | 1 | 2021 | 2319 | 0.090 |
Why?
|
Biopsy, Needle | 1 | 2015 | 1626 | 0.090 |
Why?
|
Sex Distribution | 1 | 2015 | 2281 | 0.090 |
Why?
|
Phenotype | 3 | 2019 | 16591 | 0.090 |
Why?
|
Multiprotein Complexes | 1 | 2017 | 1118 | 0.090 |
Why?
|
Age Distribution | 1 | 2015 | 2880 | 0.080 |
Why?
|
Patient Care Team | 1 | 2021 | 2521 | 0.080 |
Why?
|
Adult | 9 | 2024 | 221177 | 0.080 |
Why?
|
Age of Onset | 1 | 2016 | 3305 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2019 | 3639 | 0.080 |
Why?
|
Tomography, Optical Coherence | 1 | 2021 | 2917 | 0.070 |
Why?
|
Physician-Patient Relations | 1 | 2021 | 3249 | 0.070 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2017 | 2057 | 0.070 |
Why?
|
Escherichia coli | 1 | 2020 | 4217 | 0.070 |
Why?
|
Administration, Oral | 1 | 2015 | 4021 | 0.070 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4853 | 0.070 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2007 | 103 | 0.070 |
Why?
|
Mesenchymal Stem Cells | 1 | 2017 | 1642 | 0.070 |
Why?
|
Antigens, Ly | 1 | 2007 | 295 | 0.070 |
Why?
|
Transcription Factor RelA | 1 | 2007 | 254 | 0.070 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4740 | 0.060 |
Why?
|
Blood Pressure | 1 | 2021 | 8481 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3358 | 0.060 |
Why?
|
Lectins, C-Type | 1 | 2007 | 585 | 0.060 |
Why?
|
Male | 8 | 2024 | 360804 | 0.060 |
Why?
|
Child, Preschool | 2 | 2017 | 42230 | 0.060 |
Why?
|
Treatment Outcome | 2 | 2024 | 64680 | 0.060 |
Why?
|
Female | 8 | 2024 | 392644 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3084 | 0.050 |
Why?
|
Aging | 1 | 2021 | 8708 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11076 | 0.050 |
Why?
|
Middle Aged | 6 | 2019 | 220895 | 0.050 |
Why?
|
Hypertension | 1 | 2021 | 8540 | 0.050 |
Why?
|
Gene Frequency | 1 | 2007 | 3606 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8654 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2015 | 8547 | 0.040 |
Why?
|
Prognosis | 2 | 2019 | 29625 | 0.040 |
Why?
|
Bandages | 1 | 2020 | 269 | 0.040 |
Why?
|
Forearm | 1 | 2021 | 427 | 0.040 |
Why?
|
Administration, Cutaneous | 1 | 2020 | 713 | 0.040 |
Why?
|
Killer Cells, Natural | 1 | 2007 | 2200 | 0.040 |
Why?
|
Incidence | 1 | 2015 | 21353 | 0.040 |
Why?
|
Phosphorylation | 2 | 2019 | 8320 | 0.030 |
Why?
|
Pilot Projects | 2 | 2021 | 8631 | 0.030 |
Why?
|
Maximum Tolerated Dose | 1 | 2019 | 883 | 0.030 |
Why?
|
Cohort Studies | 2 | 2017 | 41487 | 0.030 |
Why?
|
Infant | 1 | 2017 | 36192 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2019 | 2265 | 0.030 |
Why?
|
Galectins | 1 | 2017 | 295 | 0.030 |
Why?
|
Risk Assessment | 1 | 2015 | 23995 | 0.030 |
Why?
|
Signal Transduction | 1 | 2017 | 23445 | 0.030 |
Why?
|
Risk Factors | 1 | 2020 | 74206 | 0.030 |
Why?
|
Child | 2 | 2019 | 80153 | 0.030 |
Why?
|
Health Services Needs and Demand | 1 | 2020 | 1403 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2020 | 1089 | 0.030 |
Why?
|
Blood Proteins | 1 | 2017 | 1173 | 0.020 |
Why?
|
Aged | 3 | 2021 | 169289 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2007 | 11903 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2020 | 2226 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2020 | 3688 | 0.020 |
Why?
|
Receptors, NK Cell Lectin-Like | 1 | 2007 | 30 | 0.020 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily A | 1 | 2007 | 21 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2017 | 14414 | 0.020 |
Why?
|
NF-kappa B p52 Subunit | 1 | 2007 | 35 | 0.020 |
Why?
|
Cell Aggregation | 1 | 2007 | 239 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2023 | 58976 | 0.020 |
Why?
|
Disease Progression | 1 | 2021 | 13506 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2007 | 1351 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2007 | 1756 | 0.010 |
Why?
|
Down-Regulation | 1 | 2007 | 2919 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2007 | 3162 | 0.010 |
Why?
|
Mice | 2 | 2017 | 81525 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2007 | 5789 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 30052 | 0.010 |
Why?
|
Cell Line | 1 | 2007 | 15601 | 0.010 |
Why?
|
United States | 1 | 2020 | 72334 | 0.010 |
Why?
|
Animals | 2 | 2017 | 168459 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2007 | 16981 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2007 | 22169 | 0.000 |
Why?
|
Concepts
(135)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(17)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_